Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Advanced Search

Search

You could also try: organization (363), institution (92), establishment (61), foundation (1000), association (155), society (209), introduce (203)

Regorafenib

Description: Chemotherapy Protocol Hepatocellular Cancer Regorafenib Regimen • Hepatocellular – Regorafenib Indication • Regorafenib is recommended as an option for t
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Hepatobiliary/Regorafenib.pdf

NilotinibChronic

Description: Chemotherapy Protocol Chronic Myeloid Leukaemia Nilotinib (chronic phase) Regimen • CML – Nilotinib (chronic phase) Indication • As an option for the tr
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CML/NilotinibChronic.pdf

NilotinibAccelerated

Description: Chemotherapy Protocol Chronic Myeloid Leukaemia Nilotinib (accelerated phase) Regimen • CML – Nilotinib (accelerated phase) Indication • Nilotinib is an
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CML/NilotinibAccelerated.pdf

Example SOP - 811 SOP for Tea making

Description: Tamford RESEARCH INSTITUTE Building for Beverage Research Standard Operating Procedure for making a single mug of tea with milk using an
Url: /Media/Southampton-Clinical-Research/Procedures/BRCProcedures/Example-SOP---811-SOP-for-Tea-making.pdf

ACCORD-2 steering committee

Description: ACCORD Study Oversight Committee Chair: Professor Tom Wilkinson Professor of Respiratory Medicine and Honorary NHS Consultant Physician Clinical a
Url: /Media/Southampton-Clinical-Research/COVID-19/ACCORD/ACCORD-2-steering-committee.pdf

Dr Chris Stock, head of communications and strategy

Description: Auto Generated Title Chris works with our leadership to develop our research strategy and culture, and directs our work to engage the public, clin
Url: /ClinicalResearchinSouthampton/Our-people/Communications,-engagement-and-involvement/Dr-Chris-Stock,-head-of-communications-and-strategy.aspx

Prof Tim Elliott, experimental oncology

Description: NIHR CRUK Experimental Cancer Medicine Centre Auto Generated Title Professor Elliott ’ s research looks at how the body prepares viruses and cancer c
Url: /ClinicalResearchinSouthampton/Our-people/Cancer-research-people/Prof-Tim-Elliott.aspx

Erdafitinib

Description: Regimen • Urothelial - Erdafitinib Chemotherapy Protocol UROTHELIAL CANCER ERDAFITINIB Indication • Monotherapy treatment of unresectable or metastatic urothelial
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Bladdercancer/Erdafitinib.pdf

Annual-report-201617

Description: ANNUAL REPORT AND ACCOUNTS 2016/17 incorporating the quality account 2016/17 Presented to Parliament pursuant to Schedule 7, paragraph 25 (4) (a) of the National Health
Url: /Media/UHS-website-2019/Docs/About-the-Trust/Annual-reports-and-quality-accounts/annual-report-2016171.pdf

BRC Research Theme Lead JD and PS

Description: National Institute for Health Research Southampton Biomedical Research Centre : NIHR BRC Theme Lead National Institute for Health Research (NIHR) Biomedical Researc
Url: /Media/Southampton-Clinical-Research/Downloads/BRC-Research-Theme-Lead-JD-and-PS.doc

11 to 20 of 343

Previous 1 2 3 4 5 … Next